153 related articles for article (PubMed ID: 33298007)
1. Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease.
Collins DC; Sundar R; Constantinidou A; Dolling D; Yap TA; Popat S; O'Brien ME; Banerji U; de Bono JS; Lopez JS; Tunariu N; Minchom A
BMC Cancer; 2020 Dec; 20(1):1210. PubMed ID: 33298007
[TBL] [Abstract][Full Text] [Related]
2.
Elliott HS; Metser U; de Perrot M; Cho J; Bradbury P; Veit-Haibach P; Hussey D; Noam T
Br J Radiol; 2018 Jun; 91(1086):20170814. PubMed ID: 29498536
[TBL] [Abstract][Full Text] [Related]
3. Gender-based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma.
Barsky AR; Ahern CA; Venigalla S; Verma V; Anstadt EJ; Wright CM; Ludmir EB; Berlind CG; Lindsay WD; Grover S; Cengel KA; Simone CB
Clin Lung Cancer; 2020 Nov; 21(6):e583-e591. PubMed ID: 32611504
[TBL] [Abstract][Full Text] [Related]
4. Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival.
Verma V; Ahern CA; Berlind CG; Lindsay WD; Shabason J; Sharma S; Culligan MJ; Grover S; Friedberg JS; Simone CB
Clin Lung Cancer; 2018 Nov; 19(6):e901-e912. PubMed ID: 30224273
[TBL] [Abstract][Full Text] [Related]
5. Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications.
Forest F; Patoir A; Dal Col P; Sulaiman A; Camy F; Laville D; Bayle-Bleuez S; Fournel P; Habougit C
Pathology; 2018 Oct; 50(6):635-641. PubMed ID: 30145072
[TBL] [Abstract][Full Text] [Related]
6. Malignant pleural mesothelioma in Singapore.
Yip CS; Koong HN; Loo CM; Fong KW
Asian Pac J Cancer Prev; 2011; 12(5):1155-9. PubMed ID: 21875258
[TBL] [Abstract][Full Text] [Related]
7. Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural Mesothelioma.
Espinoza-Mercado F; Borgella JD; Berz D; Alban RF; Sarkissian A; Imai HTA; Soukiasian HJ
Ann Thorac Surg; 2019 Sep; 108(3):889-896. PubMed ID: 31004585
[TBL] [Abstract][Full Text] [Related]
8. Treatment of malignant pleural mesothelioma with chemotherapy preceding versus after surgical resection.
Verma V; Ahern CA; Berlind CG; Lindsay WD; Grover S; Friedberg JS; Simone CB
J Thorac Cardiovasc Surg; 2019 Feb; 157(2):758-766.e1. PubMed ID: 30454981
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy Versus Supportive Care for Unresected Malignant Pleural Mesothelioma.
Verma V; Wegner RE; Brooks ED; Miccio JA; Kann BH; Finley GG; Raj MS; Grover S; Mohindra P; Simone CB
Clin Lung Cancer; 2019 Jul; 20(4):263-269. PubMed ID: 30992187
[TBL] [Abstract][Full Text] [Related]
10. Immune biomarkers PD-1/PD-L1 and TLR3 in malignant pleural mesotheliomas.
Combaz-Lair C; Galateau-Sallé F; McLeer-Florin A; Le Stang N; David-Boudet L; Duruisseaux M; Ferretti GR; Brambilla E; Lebecque S; Lantuejoul S
Hum Pathol; 2016 Jun; 52():9-18. PubMed ID: 26980049
[TBL] [Abstract][Full Text] [Related]
11. Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study.
de Boer NL; van Kooten JP; Damhuis RAM; Aerts JGJV; Verhoef C; Madsen EVE
Ann Surg Oncol; 2019 Dec; 26(13):4222-4228. PubMed ID: 31620941
[TBL] [Abstract][Full Text] [Related]
12. Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
Lococo F; Torricelli F; Lang-Lazdunski L; Veronesi G; Rena O; Paci M; Casadio C; Piana S; Novellis P; Di Stefano TS; Ciarrocchi A; Billè A
J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1584-1593.e2. PubMed ID: 31590954
[TBL] [Abstract][Full Text] [Related]
13. The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study.
Zauderer MG; Martin A; Egger J; Rizvi H; Offin M; Rimner A; Adusumilli PS; Rusch VW; Kris MG; Sauter JL; Ladanyi M; Shen R
Lancet Digit Health; 2021 Sep; 3(9):e565-e576. PubMed ID: 34332931
[TBL] [Abstract][Full Text] [Related]
14. Analysis of survival of patients with metastatic malignant pleural mesothelioma.
Billè A; Okiror L; Harling L; Pernazza F; Muzio A; Roveta A; Grosso F
Tumori; 2021 Apr; 107(2):110-118. PubMed ID: 32458750
[TBL] [Abstract][Full Text] [Related]
15. Radical Hemithoracic Radiotherapy Versus Palliative Radiotherapy in Non-metastatic Malignant Pleural Mesothelioma: Results from a Phase 3 Randomized Clinical Trial.
Trovo M; Relevant A; Polesel J; Muraro E; Barresi L; Drigo A; Baresic T; Bearz A; Fanetti G; Del Conte A; Matrone F; Reverberi C; Furlan C; Zuccon U; Fontana P; Franchin G; Minatel E
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1368-1376. PubMed ID: 33259933
[TBL] [Abstract][Full Text] [Related]
16. Brain metastases in malignant pleural mesothelioma.
Yamagishi T; Fujimoto N; Miyamoto Y; Asano M; Fuchimoto Y; Wada S; Kitamura K; Ozaki S; Nishi H; Kishimoto T
Clin Exp Metastasis; 2016 Mar; 33(3):231-7. PubMed ID: 26620209
[TBL] [Abstract][Full Text] [Related]
17. Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma.
Baldini EH; Richards WG; Gill RR; Goodman BM; Winfrey OK; Eisen HM; Mak RH; Chen AB; Kozono DE; Bueno R; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2015 May; 149(5):1374-81. PubMed ID: 25772281
[TBL] [Abstract][Full Text] [Related]
18. Treatment patterns among patients with malignant pleural mesothelioma: An Italian, population-based nationwide study.
Trama A; Proto C; Signorelli D; Garassino MC; Lo Russo G; Ganzinelli M; Prelaj A; Mensi C; Gangemi M; Gennaro V; Chellini E; Caldarella A; Angelillo IF; Ascoli V; Pascucci C; Tagliabue G; Cusimano R; Bella F; Falcini F; Merler E; Masanotti G; Ziino A; Michiara M; Gola G; Storchi C; Mangone L; Vitale MF; Cirilli C; Tumino R; Scuderi T; Fanetti AC; Piffer S; Tiseo M; Gatta G; Botta L;
Thorac Cancer; 2020 Jun; 11(6):1661-1669. PubMed ID: 32364316
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
20. Trimodality Treatment of Malignant Pleural Mesothelioma: An Institutional Review.
Kapeles M; Gensheimer MF; Mart DA; Sottero TL; Kusano AS; Truong A; Farjah F; Laramore GE; Stelzer KJ; Patel SA
Am J Clin Oncol; 2018 Jan; 41(1):30-35. PubMed ID: 26353120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
